The effects of a low-dose monophasic preparation of levonorgestrel and ethinyl estradiol on coagulation and other hemostatic factors

American Journal of Obstetrics and Gynecology

Volumn 181, Issue 5 II, 1999, Pages

  Archer, D F ^a   Mammen, E F ^a   Grubb, G S ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Anticoagulant; Coagulation; Ethinyl estradiol; Fibrinolysis; Levonorgestrel; Oral contraceptives

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; D DIMER; ETHINYLESTRADIOL PLUS LEVONORGESTREL; FIBRINOGEN; PLASMINOGEN; PROTEIN S; THROMBIN ANTITHROMBIN COMPLEX; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEMOSTASIS; HUMAN; MENSTRUAL CYCLE; NORMAL HUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME;

EID: 0032704331     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9378(99)70366-2     Document Type: Article

References (17)

1. BV Stadel Oral contraceptives and cardiovascular disease N Engl J Med 305 1981 612 618
2. G Samsioe LA Mattsson Some aspects of the relationship between oral contraceptives, lipid abnormalities and cardiovascular disease Am J Obstet Gynecol 163 1990 354 358
3. GB Melis F Fruzzetti I Nicoletti C Ricci P Lammers WJ Atsma A comparative study on the effects of a monophasic pill containing desogestrel plus 20 micrograms ethinyl estradiol, a triphasic combination containing levonorgestrel and a monophasic combination containing gestogen on coagulatory factors Contraception 43 1991 23 31
4. I Daly J Bonnar Comparative studies of 30 μg ethinyl estradiol combined with gestogen and desogestrel on blood coagulation, fibrinolysis, and platelets Am J Obstet Gynecol 163 1990 430 437
5. A Sabra J Bonnar Hemostatic changes induced by 50 μg and 30 μg oestrogen/progestogen oral contraceptives J Reprod Med 28 1983 85 91
6. JB Castillo AM Farag EF Mammen RJ Sachs Prothrombin times and clottable fibrinogen determination on an Automated Coagulation Laboratory (ACL-810) Thromb Res 55 1989 213 219
7. EF Mammen AM Farag T Ozawa Gerinnungsbestimmungen am Zentrifugalanalysator: Messung mit chromogenen Substraten und mit der Fibringerinnung Haemostasesologie 11 1991 8 11
8. S Hirokawa EF Mammen A functional protein S and microlatex immunoassay for protein S and C4b-binding protein on the Automated Coagulation Laboratory (ACL) 300 Plus Clin Appl Thromb Hemost 2 1996 268 275
9. A Basdevant J Conard C Pelissier TT Guyene C Lapousterle M Mayer Hemostatic and metabolic effects of lowering the ethinyl-estradiol dose from 30 μg to 20 μg in oral contraceptives containing desogestrel Contraception 48 1993 193 204
10. UH Winkler AE Schindler J Endrikat B Dusterberg A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 μg and 30 μg ethinyl estradiol Contraception 53 1996 75 84
11. UH Winkler T Holscher H Shulte JP Zierleyn W Collet AE Schindler Ethinyl estradiol 20 versus 30 μg combined with 150 μg desogestrel: a large comparative study of the effects of two low-dose oral contraceptives on the hemostatic system Gynecol Endocrinol 10 1996 265 271
12. UH Winkler Effects on hemostatic variables of desogestrel- and gestogen-containing oral contraceptives in comparison with levonorgestrel-containing oral contraceptives: a review Am J Obstet Gynecol 179 1998 S51 S61
13. UH Winkler C Oberoff U Bier AE Schindler D Gillain Hemostatic effects of two oral contraceptives containing low doses of ethinyl estradiol and either gestogen or norgestimate: an open randomized parallel-group study Int J Fertil 40 1995 260 268
14. L Norris J Bonnar The effect of oestrogen dose and progestogen type on hemostatic changes in women taking low dose oral contraceptives Br J Obstet Gynaecol 103 1996 261 267
15. P Quehenberger S Kapiotis C Partan B Schneider R Wenzel A Gaiger Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells Ann Hematol 67 1993 33 36
16. J Gram S Munkvad J Jespersen Enhanced generation and resolution of fibrin in women above the age of 30 years using oral contraceptives low in estrogen Am J Obstet Gynecol 163 1990 430 442
17. UH Winkler S Koslowski AE Schindler PAI activity is reduced in users or oral contraceptives-influence of estrogen content [abstract] Thromb Haemost 62 1989 394